NCT05304143

Brief Summary

Background: Claustrophobia is the most common type of specific phobia, and in the context of performing an MRI, it leads to premature completion of the test or a sedation. According to some authors, 1,6% of the patients terminated the test prematurely due to claustrophobia, and, in addition, 3.8% underwent conscious sedation. These procedures increase the risk of complications, and the cost of care. The use of anxiolytics is an option to reduce anxiety, but these drugs carry the possibility of suffering adverse effects, and the fact that patients cannot drive home when the MRI is finished. For these reasons, it is especially relevant to determine which non-pharmacological interventions are most effective, and among them, the use of Immersive Entertainment Glasses is a low-interventionist option that can help to overcome fear of the test. Objective: To determine the effectiveness of Immersive Entertainment Glasses in the success of the performance of an MRI and in the reduction of anxiety levels, in patients who express having claustrophobia. Methodology: Design: Clinical trial with intervention and control group. Participants: patients who define themselves as claustrophobic and should have an MRI. The sample will be made up of 206 individuals, divided between an intervention group and a control group. expecting a 20% difference between the success of the test of the control and intervention group subjects. People who meet the inclusion criteria will be distributed into the control or intervention group. The intervention group will use the Immersive Entertainment Glasses to perform the MRI and the control group will have the support of the nurse through educational techniques. Expected results: the success rate in performing MRIs is expected to increase by 20%, thanks to the use of Immersive Entertainment Glasses. Expected duration: 12 months, or until obtaining the expected sample.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
206

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

January 1, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 31, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 3, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 3, 2022

Completed
Last Updated

November 25, 2022

Status Verified

November 1, 2022

Enrollment Period

10 months

First QC Date

July 29, 2021

Last Update Submit

November 21, 2022

Conditions

Keywords

Immersive Entertainment RealityClaustrophobiaMagnetic Resonance Imaging (MRI)

Outcome Measures

Primary Outcomes (2)

  • Succes in the performance of an MRI

    Number of patients that will finish the MRI

    One hour

  • Anxiety reduction

    Decrease of the levels of anxiety measured with the State Trait Anxiety Inventory (STAI)

    One hour

Secondary Outcomes (3)

  • Image quality

    Half an hour

  • Failed MRI

    One hour

  • Patient satisfaction

    One hour

Study Arms (2)

Virtual Reality intervention group

EXPERIMENTAL

The exploration in the intervention group will be carried out with virtual reality glasses compatible with the magnetic resonance imaging equipment.

Other: Virtual Immersive Reality Glasses

Conventional nurse support

ACTIVE COMPARATOR

The exploration in the control group will be carried out with the standard procedure for claustrophobic patients that includes close nursing support.

Other: Conventional nurse support

Interventions

The day of the examination, the patient will go to the MRI room and he will be fitted with virtual reality glasses compatible with the MRI equipment. The patient will visualize relaxing contents in open spaces with music and verbal instructions during all the procedure. The contents will be previously validated by the clinical psychologist of the center with experience in this regard. During the test, the patient's heart rate will be monitored.

Virtual Reality intervention group

Patients will be treated using the usual support technique to reduce anxiety in the Diagnostic Imaging service

Conventional nurse support

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with self-reported fear of enclosed spaces
  • Patients with fear of having an MRI

You may not qualify if:

  • Patients who must undergo a sustained breathing exploration during the test
  • Patients who have a contraindicated MRI
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mútua de Terrassa

Terrassa, Barcelona, 08221, Spain

Location

Related Publications (10)

  • Carpenter JK, Moskow DM, Hofmann SG. Enhanced Mental Reinstatement of Exposure to Improve Extinction Generalization: A Study on Claustrophobia and MRI Fear. Behav Ther. 2023 Jan;54(1):156-169. doi: 10.1016/j.beth.2022.08.002. Epub 2022 Aug 13.

    PMID: 36608973BACKGROUND
  • Brown RKJ, Petty S, O'Malley S, Stojanovska J, Davenport MS, Kazerooni EA, Fessahazion D. Virtual Reality Tool Simulates MRI Experience. Tomography. 2018 Sep;4(3):95-98. doi: 10.18383/j.tom.2018.00023.

    PMID: 30320208BACKGROUND
  • Pull CB. Recent trends in the study of specific phobias. Curr Opin Psychiatry. 2008 Jan;21(1):43-50. doi: 10.1097/YCO.0b013e3282f30086.

    PMID: 18281840BACKGROUND
  • Rahani VK, Vard A, Najafi M. Claustrophobia Game: Design and Development of a New Virtual Reality Game for Treatment of Claustrophobia. J Med Signals Sens. 2018 Oct-Dec;8(4):231-237. doi: 10.4103/jmss.JMSS_27_18.

    PMID: 30603615BACKGROUND
  • Tugwell JR, Goulden N, Mullins P. Alleviating anxiety in patients prior to MRI: A pilot single-centre single-blinded randomised controlled trial to compare video demonstration or telephone conversation with a radiographer versus routine intervention. Radiography (Lond). 2018 May;24(2):122-129. doi: 10.1016/j.radi.2017.10.001. Epub 2017 Oct 31.

    PMID: 29605108BACKGROUND
  • Garcia-Palacios A, Hoffman HG, Richards TR, Seibel EJ, Sharar SR. Use of virtual reality distraction to reduce claustrophobia symptoms during a mock magnetic resonance imaging brain scan: a case report. Cyberpsychol Behav. 2007 Jun;10(3):485-8. doi: 10.1089/cpb.2006.9926.

    PMID: 17594277BACKGROUND
  • King S, Woodley J, Walsh N. A systematic review of non-pharmacologic interventions to reduce anxiety in adults in advance of diagnostic imaging procedures. Radiography (Lond). 2021 May;27(2):688-697. doi: 10.1016/j.radi.2020.09.018. Epub 2020 Oct 4.

    PMID: 33028496BACKGROUND
  • Spielberger CD Lushene PR, Jacobs GA. GRL. Manual for the State-Trait Anxiety Inventory. Consult Psychol Press. 1983.

    BACKGROUND
  • Vadakkan C, Siddiqui W. Claustrophobia. 2023 Feb 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK542327/

    PMID: 31194467BACKGROUND
  • Diaz-Membrives M, Garrido-Ribas I, Caro-Benito C, Font-Cabrera C, Monistrol O. Claustrophobia in magnetic resonance imaging: A randomised controlled trial of immersive entertainment glasses. Radiography (Lond). 2026 Jan 3;32(2):103318. doi: 10.1016/j.radi.2025.103318. Online ahead of print.

MeSH Terms

Conditions

Claustrophobia

Condition Hierarchy (Ancestors)

Phobic DisordersAnxiety DisordersMental Disorders

Study Officials

  • Montserrat Díaz Membrives, PhD

    Supervisor of Imaging Diagnostics

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2021

First Posted

March 31, 2022

Study Start

January 1, 2022

Primary Completion

November 3, 2022

Study Completion

November 3, 2022

Last Updated

November 25, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

IPD will not be shared

Locations